Staar Warning Letter Presents Challenges For ICL Approval Timeline
This article was originally published in The Gray Sheet
Executive Summary
Staar Surgical continues to anticipate approval for the Collamer ICL implantable contact lens by April, despite compliance issues raised in a Dec. 22 FDA warning letter
You may also be interested in...
Staar Will Respond To FDA On “Serious, Continuing Violations”
Staar Surgical said it would issue a report to FDA July 15 detailing the firm's plans for resolving a series of quality systems violations
Staar Will Respond To FDA On “Serious, Continuing Violations”
Staar Surgical said it would issue a report to FDA July 15 detailing the firm's plans for resolving a series of quality systems violations
Staar Tackles Compliance Issues; AMO Sets Sights On Overseas Lens Market
Staar Surgical will create a dedicated compliance office as part of an operational restructuring to boost its regulatory standing in the wake of two warning letters issued by FDA since December